Brief: Xeris Biopharma Reports Q3 2024 Financial Results

Xeris Biopharma Holdings

08/11/2024 12:26

Nov 8 (Reuters) - Xeris Biopharma Holdings Inc  XERS.O :
    * XERIS BIOPHARMA REPORTS THIRD QUARTER 2024 FINANCIAL
RESULTS
    * XERIS BIOPHARMA HOLDINGS: RAISES FY GUIDANCE OF TOTAL NET
REVENUE TO $198 MILLION - $202MLN & TIGHTENS YEAR-END CASH TO
$68MLN - $72MLN
    * XERIS BIOPHARMA HOLDINGS: CASH, CASH EQUIVALENTS, &
SHORT-TERM
INVESTMENTS AT SEPT 30, 2024 WAS $69.4 MILLION

Source text:  ID:nBwVNBcfa 
Further company coverage:  XERS.O 

 ((Reuters.Briefs@thomsonreuters.com;))